Added to YB: 2024-05-22
Pitch date: 2024-05-22
ANNX [bullish]
Annexon, Inc.
+3.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.
Market Cap
$728.9M
Pitch Price
$4.91
Price Target
N/A
Dividend
N/A
EV/EBITDA
-2.70
P/E
-3.53
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ANNEXON INC ANNX
A summary for this pitch has not been created yet.
Read full article (0 min)